The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Hanixol 50 mg Tablets

Fontus Health LimitedPA22756/001/001

Main Information

Trade NameHanixol 50 mg Tablets
Active SubstancesMercaptopurine
Dosage FormTablet
Licence HolderFontus Health Limited
Licence NumberPA22756/001/001

Group Information

ATC CodeL01BB Purine analogues
L01BB02 mercaptopurine


License statusAuthorised
Licence Issued19/08/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back